IKT

Conviction 93HealthcareScan · Thu, Jun 25, 2026

IKT$1.87+0.00%

ResistanceSupportVol 14

Vol MA14 713.14K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Inhibikase Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.inhibikase.com ↗

Price1.87

Change+0.00%

Gap-0.53%

Rel volume1.99×

Avg volume652.06K

Avg $ vol1.14M

SMA 201.72

SMA 501.79

SMA 2001.70

Price vs 50+4.59%

Price vs 200+9.72%

MA stackbullish

50/200 cross—

Supertrenddown · 1.90

RSI (14)64

MACD hist0.03

MACD crossbull · 8d

Stoch %K / %D83 / 87

ADX (14)17

+DI / −DI24 / 12

RSI divergence—

MACD divergence—

ATR %+4.57%

ADR %4.40%

52w high2.14

52w low1.41

From 52w high-12.62%

Above 52w low+32.62%

New 52w highNo

SqueezeOff

Bollinger width19.38%

%B0.94

Donchian pos82.81%

Donchian high1.93

Donchian low1.61

AVWAP (52w high)1.82

vs AVWAP high+2.89%

AVWAP (52w low)1.80

vs AVWAP low+3.66%

OBV trendFlat

Chaikin MF (20)-0.10

Today vs 20d1.99×

Avg vol (14d)713.14K

Avg vol (20d)652.06K

Avg $ vol (20d)1.14M

Market cap246.9M

RS 3m (vs SPY)+4.62%

RS 6m (vs SPY)+0.98%

RS line new highNo

Trend template8/8

Technical rank77.7

1 week+11.31%

1 month+10.00%

3 months+14.72%

6 months+12.65%

1 year+12.65%

YTD-4.10%

P/E-5.12

P/B1.47

P/S—

P/FCF-8.88

EPS-0.4900

Div yield—

ROE-28.79%

ROA-27.84%

Debt/Eq0.00

Current30.14

EV/EBITDA—

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-75.36%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value68.48M

Revenue0

Net income-16.38M

Gross profit—

Free cash flow-27.8M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out132.03M

Employees35

ListedWed, Dec 23, 2020

Free float41.95M

Float %55.8%

Short interest18.51M

Days to cover24.6d

Short volume57.0%

Squeeze score91 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction93 / 100

Pattern quality—

Tech rank77.7 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.96

Support1.57

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IKT

All disclosures →

No recent disclosed trades by Congress in IKT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IKT

No recent insider (Form 4) filings in IKT. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in IKT

EDGAR →

No recent SEC filings on file for IKT.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.